Goose Parvovirus Vaccine Description
This live attenuated vaccine is developed using a duck-embryo-adapted gosling plague virus strain (GD), providing effective protection against gosling plague (goose parvovirus infection), a highly contagious and often fatal disease affecting young goslings.
Gosling plague is characterized by high mortality, severe enteritis, and growth retardation, causing significant economic losses in goose production systems. Control of this disease relies heavily on maternal antibody transfer from vaccinated breeding geese to their offspring.
This vaccine is specifically designed for pre-laying immunization of breeding geese, enabling the production of high levels of maternal antibodies. As a result, goslings hatched from vaccinated geese between 21 and 270 days post-vaccination receive effective passive immunity against the disease.
The vaccine demonstrates strong immunogenicity and is suitable for integration into breeder flock vaccination programs to ensure consistent protection of young birds during their most vulnerable stage.
예방 접종 프로그램
- Breeding Geese:
- 접종하십시오 20–30 days before laying
- Maternal Immunity:
- Offspring protected from 21 to 270 days post-vaccination
용량 및 투여 방법
- Route: Intramuscular injection
- 용량:
- 1.0 mL per bird (1 dose)
- 라벨 지침에 따라 멸균 생리식염수로 희석
- 용해 후 즉시 사용하십시오
구성
- Attenuated gosling plague virus (strain GD): ≥ 10³.⁰ ELD50 per dose
제품 특성
- Appearance: Sponge-like loose mass
- 바이알 벽에서 쉽게 분리됨
- 희석 후 신속하게 용해됨
안전성 및 주의사항
- Do NOT vaccinate goslings directly
- Use only in breeding geese
- 희석 후:
- 서늘하고 어두운 곳에 보관하십시오
- 4시간 이내에 사용하십시오
- 무균 주사 절차를 유지하십시오.
- Disinfect injection site before administration
- 폐기하십시오:
- 백신 바이알
- 장비
- 잔여 백신은 생물안전 프로토콜에 따라 처리하십시오
포장 및 규격
- 규격:
- 1000두분/바이알
- 2000두/바이알
- 포장: 10바이알/박스
보관 및 유효 기간
- 보관: 2–8°C
- 차광 보관
- 유효 기간: 24개월
